Stay updated with breaking news from Matthew Dallos. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The second phase of a study evaluating androgen receptor inhibitor masofaniten combined with antiandrogen Xtandi for the treatment of patients with metastatic castration-resistant prostate cancer has been launched.
/PRNewswire/ -- The Prostate Cancer Foundation (PCF) today announced the 2022 Class of PCF Team Challenge Award recipients and a total of more than $12 million...
More than a dozen students are taking part in the 2022 Cornell Biennial, which aims to serve as an anchor for the arts at Cornell and bring artists from around the world to campus.